Scott E. Eggener to Neoplasms, Experimental
This is a "connection" page, showing publications Scott E. Eggener has written about Neoplasms, Experimental.
Connection Strength
0.014
-
Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer. Clin Cancer Res. 2005 Jul 01; 11(13):4905-11.
Score: 0.014